Circulating levels of interleukin-8 and vascular endothelial growth factor in patients with carotid stenosis

Journal of Korean Medical Science

Volumn 16, Issue 2, 2001, Pages 198-203

  Lee, Sang Hwa ^a   Jeong, Min Ho ^a   Bae, Hae Rhan ^a   Jeong, Soo Jin ^a   Jang, Ji Yeon ^a   Lim, Yeong Jin ^a   Kim, Sang Ho ^a   Kim, Jae Woo ^a   Cha, Jae Kwan ^a  

^a Dong A University   (South Korea)

Author keywords

Atherosclerosis; Carotid Stenosis; Endothelial Growth Factors; Endothelium, Vascular; Interleukin 8

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR; INTERLEUKIN 8; LYMPHOKINE; VASCULOTROPIN; VASCULOTROPIN A;

ADULT; AGED; ARTICLE; BLOOD; CAROTID ARTERY DISEASE; CAROTID ARTERY OBSTRUCTION; DISEASE COURSE; FEMALE; HUMAN; MALE; MIDDLE AGED;

ADULT; AGED; CAROTID ARTERY DISEASES; CAROTID STENOSIS; DISEASE PROGRESSION; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; INTERLEUKIN-8; LYMPHOKINES; MALE; MIDDLE AGED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035319453     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2001.16.2.198     Document Type: Article

References (35)

1. Fowler S, Berberian P, Shio H, Goldfischer S, Wolinsky H. Characterization of cell populations isolated from aortas of rhesus monkeys with experimental atherosclerosis. Circ Res 1980; 46: 520-30.
2. Joris I, Zand T, Nunnari JJ, Krolikowski FJ, Majno G. Studies on the pathogenesis of atherosclerosis. I: Adhesion and emigration of mononuclear cells in the aorta of hypercholesterolemic rats. Am J Pathol 1983; 113: 341-58.
3. Munro J, Cotran RS. The pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab Invest 1988; 58: 249-61.
4. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27-31.
5. Schaper W, Ito WD. Molecular mechanisms of coronary collateral vessel growth. Circ Res 1996; 79: 911-9.
6. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Einer VM, Einer SG, Strieter RM. Interleukin-8 as macrophage-derived mediator of angiogenesis. Science 1992; 258: 1798-801.
7. Strieter RM, Kunkel SL, Elner VM, Martonyi CL, Koch AE, Polverini PJ, Elner SG. Interleukin-8: a corneal factor that induces neovascularization. Am J Pathol 1992; 141: 1279-84.
8. Arenberg DA, Kunkel SL, Polverini PJ, Glass M, Burdick MD, Strieter RM. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J Clin Invest 1996; 97: 2792-802.
9. Arenberg DA, Kunkel SL, Polverini PJ, Morris SB, Burdick MD, Glass MC, Taub DT, Iannettoni MD, Whyte RI, Strieter RM. Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer tumorigenesis and spontaneous metastasis. J Exp Med 1996; 184: 981-92.
10. Keane MP, Arenberg DA, Lynch JP III, Whyte RI, Iannettoni MD, Burdick MD, Wilke CA, Morris SB, Glass MC, DiGiovine B, Kunkel SL, Strieter RM. The CXC chemokines, IL-8, and IP-10 regulate angiogenic activity in idiopathic pulmonary fibrosis. J Immunol 1997; 159: 1437-43.
11. Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992; 13: 18-32.
12. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruber RM, Feder J. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989; 84: 1470-8.
13. Gospodarowicz D, Abraham JA, Schilling J. Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculostellate cells. Proc Natl Acad Sci USA 1989; 86: 7311-5.
14. Plate KH, Breier G, Weich HA, Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1992; 359: 845-8.
15. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359: 843-8.
16. Koch AE, Harlow LA, Haines GK, Amento EP, Unemori EN, Wong WL, Pope RM, Ferrara N. Vascular endothelial growth factor: a cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 1994; 152: 4149-56.
17. Fleisch M, Billinger M, Eberli FR, Garachemani AR, Meier B, Seiler C. Physiological assessed coronary collateral flow and intracoronary growth factor concentrations in patients with 1- to 3- vessel coronary artery disease. Circulation 1999; 100: 1945-50.
18. Slevin M, Krupinski J, Slowik A, Kumar P, Szczudlik A, Gaffney J. Serial measurement of vascular endothelial growth factor and transforming growth factor-beta1 in serum of patients with acute ischemic stroke. Stroke 2000; 31: 1863-70.
19. Inoue M, Itoh H, Ueda M, Naruko T, Kojima A, Komatsu R, Doi K, Ogawa Y, Tamura N, Takaya K, Igaki T, Yamashita J, Chun TH, Masatsugu K, Becker AE, Nakao K. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions; possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 1998; 98: 2108-16.
20. Apostolopoulos J, Davenport P, Tipping PG. Interleukin-8 production by macrophages from atheromatous plaques. Atheroscler Thromb Vasc Biol 1996; 16: 1007-12.
21. De Boer OJ, van der Wal AC, Teeling P, Becker AE. Leucocyte recruitment in rupture prone regions of lipid-rich plaques: a prominent role for neovascularization. Cardiovasc Res 1999; 41: 443-9.
22. Espeland F, Hoen H, Byington R, Howard G, Riley WA, Furberg CD. Spatial distribution of carotid intimal-medial thickness as measured by B-mode ultrasonography. Stroke 1994; 25: 1812-9.
23. Lazarous DF, Shou M, Scheinowitz M, Hodge E, Thirumurti V, Kitsiou AN, Stiber JA, Lobo AD, Hunsberger S, Guetta E, Epstein SE, Unger EF. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation 1996; 94: 1074-82.
24. Unemori EN, Ferrara N, Bauer EA, Amento EP. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol 1992; 153: 557-62.
25. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983; 219: 983-5.
26. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989; 246: 1309-12.
27. Clauss M, Gerlach M, Gelach H, Brett J, Wang F, Familletti PC, Pan YC, Olander JV, Connoly DT, Stem D. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulation activity, and promote monocyte migration J Exp Med 1990; 172: 1535-45.
28. Doi K, Itoh H, Komatsu Y, Igaki T, Chun TH, Takaya K, Yamashita J, Inoue M, Yamashita T, Nakao K. Vascular endothelial growth factor suppresses C-type natriuretic peptide secretion. Hypertension 1996; 27: 811-5.
29. Reap TJ, Groot PH. Chemokines and atherosclerosis. Atherosclerosis 1999; 147: 213-25.
30. Cha JK, Kim SH, Kim JW. The serum levels of interleukin-8, monocyte chemotatic protein-1 and macrophage inflammatory protein-1a in patients with acute ischemic stroke and with atherosclerosis. J Korean Neurol Assoc 2000; 18: 132-7.
31. Simiti A, Vida-Simiti L, Critea A, Olinic N. Increased plasma levels of interleukin-8 in patients with unstable angina pectoris. Rom J Intern Med 1998; 36: 47-56.
32. Pudil R, Pidrman V, Krejsek J, Gregor J, Tichy M, Andrys C, Drahosova M. Cytokines and adhesion molecules in the course of acute myocardial infarction. Clin Chim Acta 1999; 280: 127-34.
33. Kostula N, Kivisakk P, Huang Y, Matusevicius D, Kostula V, Link H. Ischemic stroke is associated with a systemic increase of blood mononuclear cells expressing interleukin-8 mRNA. Stroke 1998; 29: 462-6.
34. Van Deventer SJ, Buller HR, ten Cate JW, Aarden LA, Hack CE, Sturk A. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 1990; 76: 2520-6.
35. Sinnaeve P, Varenne O, Collen D, Janssens S. Gene therapy in the cardiovascular system: an update. Cardiovasc Res 1999; 44: 498-506.